Evanson Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.16M Sell
12,914
-77
-0.6% -$17.9K 0.17% 66
2025
Q4
$2.69M Buy
12,991
+2
+0% +$395 0.15% 72
2025
Q3
$2.41M Sell
12,989
-1,588
-11% -$272K 0.14% 79
2025
Q2
$2.23M Buy
14,577
+1,603
+12% +$246K 0.14% 78
2025
Q1
$2.15M Sell
12,974
-433
-3% -$67.8K 0.15% 74
2024
Q4
$1.94M Buy
13,407
+25
+0.2% +$3.87K 0.13% 81
2024
Q3
$2.17M Sell
13,382
-502
-4% -$80K 0.15% 74
2024
Q2
$2.03M Buy
13,884
+153
+1% +$22.8K 0.15% 73
2024
Q1
$2.17M Buy
13,731
+169
+1% +$26.9K 0.16% 70
2023
Q4
$2.13M Sell
13,562
-339
-2% -$52K 0.17% 63
2023
Q3
$2.17M Buy
13,901
+113
+0.8% +$18.6K 0.2% 55
2023
Q2
$2.28M Buy
13,788
+172
+1% +$27.8K 0.21% 54
2023
Q1
$2.11M Buy
13,616
+259
+2% +$41.8K 0.21% 52
2022
Q4
$2.36M Sell
13,357
-772
-5% -$133K 0.25% 47
2022
Q3
$2.31M Sell
14,129
-232
-2% -$39.3K 0.27% 42
2022
Q2
$2.55M Sell
14,361
-2,134
-13% -$380K 0.28% 38
2022
Q1
$2.92M Buy
16,495
+315
+2% +$53.6K 0.28% 42
2021
Q4
$2.77M Buy
16,180
+26
+0.2% +$4.26K 0.25% 43
2021
Q3
$2.65M Buy
16,154
+24
+0.1% +$4.09K 0.27% 45
2021
Q2
$2.66M Sell
16,130
-811
-5% -$134K 0.28% 45
2021
Q1
$2.78M Sell
16,941
-125
-0.7% -$20.2K 0.41% 37
2020
Q4
$2.69M Buy
17,066
+28
+0.2% +$4.13K 0.43% 35
2020
Q3
$2.54M Buy
17,038
+12
+0.1% +$1.78K 0.46% 33
2020
Q2
$2.39M Buy
17,026
+12
+0.1% +$1.75K 0.47% 32
2020
Q1
$2.23M Sell
17,014
-19
-0.1% -$2.7K 0.53% 30
2019
Q4
$2.48M Sell
17,033
-1,039
-6% -$141K 0.49% 40
2019
Q3
$2.34M Buy
18,072
+202
+1% +$26.6K 0.48% 41
2019
Q2
$2.49M Buy
17,870
+85
+0.5% +$11.8K 0.5% 37
2019
Q1
$2.49M Buy
17,785
+262
+1% +$35.1K 0.51% 38
2018
Q4
$2.26M Sell
17,523
-413
-2% -$57.6K 0.52% 37
2018
Q3
$2.48M Sell
17,936
-16,106
-47% -$2.14M 0.5% 39
2018
Q2
$4.13M Buy
34,042
+118
+0.3% +$14.7K 0.82% 24
2018
Q1
$4.35M Buy
33,924
+901
+3% +$122K 0.89% 22
2017
Q4
$4.61M Buy
33,023
+786
+2% +$109K 0.94% 20
2017
Q3
$4.19M Sell
32,237
-6
-0% -$795 0.9% 20
2017
Q2
$4.26M Sell
32,243
-204
-0.6% -$26K 0.98% 20
2017
Q1
$4.04M Sell
32,447
-51
-0.2% -$6.09K 1% 21
2016
Q4
$3.74M Sell
32,498
-763
-2% -$88.1K 1.04% 19
2016
Q3
$3.93M Sell
33,261
-742
-2% -$90K 1.12% 18
2016
Q2
$4.13M Buy
34,003
+554
+2% +$63K 1.25% 18
2016
Q1
$3.62M Sell
33,449
-432
-1% -$44.7K 1.24% 18
2015
Q4
$3.48M Buy
33,881
+226
+0.7% +$22.7K 1.27% 17
2015
Q3
$3.14M Sell
33,655
-52
-0.2% -$5.03K 1.18% 19
2015
Q2
$3.29M Buy
33,707
+2,941
+10% +$295K 1.15% 20
2015
Q1
$3.1M Sell
30,766
-472
-2% -$48K 1.11% 21
2014
Q4
$3.27M Sell
31,238
-1,589
-5% -$167K 1.21% 19
2014
Q3
$3.5M Sell
32,827
-391
-1% -$40.6K 1.43% 15
2014
Q2
$3.48M Buy
33,218
+322
+1% +$32.5K 1.34% 18
2014
Q1
$3.23M Sell
32,896
-892
-3% -$82.7K 1.42% 19
2013
Q4
$3.1M Buy
+33,788
New +$3.11M 1.38% 19

Other funds holding JNJ

Evanson Asset Management's JNJ Position: Q1 2026 in Review

Evanson Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.59% in Q1 2026, selling an estimated $17.9K and leaving 12,914 shares worth $3.16M. The position accounts for 0.17% of the portfolio, ranked #66.

Evanson Asset Management first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.61M in Q4 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Evanson Asset Management held 12,914 shares of Johnson & Johnson worth $3.16M as of Q1 2026.
  • Evanson Asset Management sold 77 Johnson & Johnson shares in Q1 2026, an estimated $17.9K.
  • Johnson & Johnson made up 0.17% of Evanson Asset Management's portfolio in Q1 2026, its #66 holding.
  • Evanson Asset Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • Evanson Asset Management's Johnson & Johnson position peaked at $4.61M in Q4 2017.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Evanson Asset Management's 13F filing for Q1 2026, filed 8 Apr 2026.